Cite
[18F]FEOBV positron emission tomography may not be a suitable method to measure parasympathetic denervation in patients with Parkinson's disease.
MLA
Horsager, Jacob, et al. “[18F]FEOBV Positron Emission Tomography May Not Be a Suitable Method to Measure Parasympathetic Denervation in Patients with Parkinson’s Disease.” Parkinsonism & Related Disorders, vol. 104, Nov. 2022, pp. 21–25. EBSCOhost, https://doi.org/10.1016/j.parkreldis.2022.09.016.
APA
Horsager, J., Okkels, N., Fedorova, T. D., Knudsen, K., Skjærbæk, C., Van Den Berge, N., Jacobsen, J., Munk, O. L., Danielsen, E. H., Bender, D., Brooks, D. J., & Borghammer, P. (2022). [18F]FEOBV positron emission tomography may not be a suitable method to measure parasympathetic denervation in patients with Parkinson’s disease. Parkinsonism & Related Disorders, 104, 21–25. https://doi.org/10.1016/j.parkreldis.2022.09.016
Chicago
Horsager, Jacob, Niels Okkels, Tatyana D. Fedorova, Karoline Knudsen, Casper Skjærbæk, Nathalie Van Den Berge, Jan Jacobsen, et al. 2022. “[18F]FEOBV Positron Emission Tomography May Not Be a Suitable Method to Measure Parasympathetic Denervation in Patients with Parkinson’s Disease.” Parkinsonism & Related Disorders 104 (November): 21–25. doi:10.1016/j.parkreldis.2022.09.016.